Clinical Trials
임상시험 트래커
국내사는 전체 임상 이력, 글로벌 메이저는 진행 중 파이프라인을 추적합니다. ClinicalTrials.gov API v2에서 6시간 주기로 수집합니다.
기업
26 results
- 3상모집 중단 (진행 중)· COVID-19A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
리드: 바이오엔테크 · 협력: 화이자
- 2상모집 중단 (진행 중)· Muscle-invasive Urothelial CarcinomaA Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)
리드: 로슈 · 협력: 바이오엔테크
- 2상모집 중단 (진행 중)· Locally Advanced Breast CancerSafety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy
리드: 바이오엔테크 · 협력: BMS
- 2상모집 중단 (진행 중)· Extensive-stage Small-cell Lung CancerSafety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy
리드: 바이오엔테크
- 3상모집 중단 (진행 중)· Triple Negative Breast Cancer(TNBC)PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic TNBC
협력: 바이오엔테크
- 3상모집 중단 (진행 중)· HER2-positive Breast CancerA Study to Compare DB-1303/BNT323 Versus T-DM1 in Breast Cancer
협력: 바이오엔테크
- 3상모집 중단 (진행 중)· Metastatic Breast CancerA Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)
협력: 바이오엔테크
- 1상모집 중단 (진행 중)· Advanced Malignant Solid TumorSafety and Preliminary Efficacy of BNT314 in Cancer Patients With Malignant Solid Tumors
리드: 바이오엔테크
- 1상모집 중단 (진행 중)· Malignant Solid TumorA Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors
협력: 바이오엔테크
- 2상모집 중단 (진행 중)· Adenocarcinoma, Pancreatic DuctalA Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC
리드: 로슈 · 협력: 바이오엔테크
- 1/2상모집 중단 (진행 중)· TuberculosisSafety and Immune Responses After Vaccination With Two Investigational RNA-based Vaccines Against Tuberculosis in BCG Vaccinated Volunteers
리드: 바이오엔테크
- 3상모집 중단 (진행 중)· Non Small Cell Lung CancerONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors
협력: 바이오엔테크
- 2상모집 중단 (진행 중)· NSCLCA Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With NSCLC
협력: 바이오엔테크
- 2상모집 중단 (진행 중)· SCLCA Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLC
협력: 바이오엔테크
- 2상모집 중단 (진행 중)· Neuroendocrine NeoplasmA Study of PM8002 in Combination With Chemotherapy in Patients With NEN
협력: 바이오엔테크
- 2상모집 중단 (진행 중)· Advanced Non-Small Cell Lung CancerA Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1)
리드: 리제네론 · 협력: 바이오엔테크
- 1상모집 중단 (진행 중)· Non Small Cell Lung CancerA Study of YL202 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer and Breast Cancer
협력: 바이오엔테크
- 1/2상모집 중단 (진행 중)· Advanced Solid TumorFirst-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors
협력: 바이오엔테크
- 1/2상모집 중단 (진행 중)· TNBCA Study of PM8002 Plus Nab-paclitaxel as First Line Therapy for TNBC
협력: 바이오엔테크
- 2상모집 중단 (진행 중)· SCLCA Study of PM8002 in Combination With Chemotherapy in Patients With SCLC
협력: 바이오엔테크
- 2상모집 중단 (진행 중)· Colorectal Cancer Stage IIA Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
리드: 바이오엔테크 · 협력: 로슈
- 2/3상모집 중단 (진행 중)· Unresectable Head and Neck Squamous Cell CarcinomaA Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1
리드: 바이오엔테크
- 1/2상모집 중단 (진행 중)· Malignant Solid TumorGEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors
협력: 바이오엔테크
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.